Robert L. Sutherland

27.5k total citations · 3 hit papers
236 papers, 19.2k citations indexed

About

Robert L. Sutherland is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Robert L. Sutherland has authored 236 papers receiving a total of 19.2k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Molecular Biology, 103 papers in Oncology and 81 papers in Genetics. Recurrent topics in Robert L. Sutherland's work include Estrogen and related hormone effects (68 papers), Cancer-related Molecular Pathways (56 papers) and Prostate Cancer Treatment and Research (27 papers). Robert L. Sutherland is often cited by papers focused on Estrogen and related hormone effects (68 papers), Cancer-related Molecular Pathways (56 papers) and Prostate Cancer Treatment and Research (27 papers). Robert L. Sutherland collaborates with scholars based in Australia, United States and United Kingdom. Robert L. Sutherland's co-authors include Elizabeth A. Musgrove, Susan M. Henshall, Christine L. Clarke, C. Elizabeth Caldon, Leigh C. Murphy, Roger J. Daly, Andrew Stone, Roger R. Reddel, Jane Barraclough and Rosemary E. Hall and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Robert L. Sutherland

234 papers receiving 18.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cyclin D as a therapeutic target in cancer

2011 1.1k citations Elizabeth A. Musgrove, C. Elizabeth Caldon et al. profile →
Biological determinants of endocrine resistance in breast cancer

2009 989 citations Elizabeth A. Musgrove, Robert L. Sutherland profile →
Progestin Regulation of Cellular Proliferation*

1990 543 citations Robert L. Sutherland et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robert L. Sutherland	10.4k	7.8k	5.0k	3.8k	3.3k	236	19.2k
Robert I. Nicholson	8.1k 0.8×	9.4k 1.2×	4.9k 1.0×	4.3k 1.1×	2.9k 0.9×	262	18.4k
Suzanne A.W. Fuqua	9.3k 0.9×	6.4k 0.8×	6.6k 1.3×	4.0k 1.0×	1.8k 0.6×	203	16.6k
Ivan Bièche	11.1k 1.1×	5.9k 0.8×	2.7k 0.5×	5.7k 1.5×	2.6k 0.8×	497	20.2k
Elizabeth A. Musgrove	7.4k 0.7×	6.6k 0.9×	3.0k 0.6×	3.2k 0.8×	2.3k 0.7×	144	13.6k
Rosette Lidereau	9.5k 0.9×	6.3k 0.8×	3.3k 0.7×	5.0k 1.3×	1.9k 0.6×	263	16.1k
Nancy E. Hynes	10.7k 1.0×	10.4k 1.3×	2.3k 0.5×	2.1k 0.6×	2.2k 0.7×	201	18.9k
John T. Isaacs	10.9k 1.0×	5.4k 0.7×	2.3k 0.5×	3.6k 0.9×	8.3k 2.5×	311	21.3k
Geoffrey J. Lindeman	10.4k 1.0×	10.9k 1.4×	2.6k 0.5×	4.7k 1.2×	2.1k 0.6×	190	18.1k
Robert B. Dickson	8.9k 0.9×	5.9k 0.8×	4.3k 0.9×	3.6k 0.9×	871 0.3×	221	16.1k
Andres J. Klein–Szanto	12.0k 1.2×	7.0k 0.9×	1.6k 0.3×	4.9k 1.3×	2.6k 0.8×	383	21.3k

Countries citing papers authored by Robert L. Sutherland

Since Specialization

Citations

This map shows the geographic impact of Robert L. Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Sutherland more than expected).

Fields of papers citing papers by Robert L. Sutherland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Sutherland. The network helps show where Robert L. Sutherland may publish in the future.

Co-authorship network of co-authors of Robert L. Sutherland

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Sutherland. A scholar is included among the top collaborators of Robert L. Sutherland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Sutherland. Robert L. Sutherland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ricciardelli, Carmela, Tina Bianco‐Miotto, Shalini Jindal, et al.. (2018). The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome. Clinical Cancer Research. 24(10). 2328–2341. 62 indexed citations

McConoughey, Stephen J., Swati Jalgaonkar, Marino E. Leon, et al.. (2013). Transcription factor ATF3 links host adaptive response to breast cancer metastasis. Journal of Clinical Investigation. 123(7). 2893–2906. 96 indexed citations

Schade, Babette, Robert Lesurf, Virginie Sanguin‐Gendreau, et al.. (2013). β-Catenin Signaling Is a Critical Event in ErbB2-Mediated Mammary Tumor Progression. Cancer Research. 73(14). 4474–4487. 71 indexed citations

Caldon, C. Elizabeth, C. Marcelo Sergio, Jian Kang, et al.. (2012). Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells. Molecular Cancer Therapeutics. 11(7). 1488–1499. 125 indexed citations

Samimi, Goli, Brian Z. Ring, D. T. Ross, et al.. (2012). TLE3 Expression Is Associated with Sensitivity to Taxane Treatment in Ovarian Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 21(2). 273–279. 17 indexed citations

Devaney, James, Clare Stirzaker, Wenjia Qu, et al.. (2011). Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers. Cancer Epidemiology Biomarkers & Prevention. 20(1). 148–159. 47 indexed citations

Mahon, Kate, Susan M. Henshall, Robert L. Sutherland, & Lisa G. Horvath. (2011). Pathways of chemotherapy resistance in castration-resistant prostate cancer. Endocrine Related Cancer. 18(4). R103–R123. 76 indexed citations

Hochgräfe, Falko, Luxi Zhang, Sandra O’Toole, et al.. (2010). Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells. Cancer Research. 70(22). 9391–9401. 141 indexed citations

Zardawi, Ibrahim M., Catriona M. McNeil, Ewan K.A. Millar, et al.. (2010). High Notch1 protein expression is an early event in breast cancer development and is associated with the HER‐2 molecular subtype. Histopathology. 56(3). 286–296. 48 indexed citations

10.

Lee, Brian Y., David A. Brown, Mark P. Molloy, et al.. (2009). Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling. Cancer Research. 69(19). 7696–7703. 86 indexed citations

11.

Peters, Amelia A., Grant Buchanan, Carmela Ricciardelli, et al.. (2009). Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer. Cancer Research. 69(15). 6131–6140. 309 indexed citations

12.

O’Toole, Sandra, et al.. (2009). Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer.. PubMed. 24(3). 385–98. 99 indexed citations

13.

Millar, Ewan K.A., Peter Graham, Sandra A. O’Toole, et al.. (2009). Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel. Journal of Clinical Oncology. 27(28). 4701–4708. 247 indexed citations

14.

Alles, M. Chehani, Margaret Gardiner‐Garden, David J. Nott, et al.. (2009). Meta-Analysis and Gene Set Enrichment Relative to ER Status Reveal Elevated Activity of MYC and E2F in the “Basal” Breast Cancer Subgroup. PLoS ONE. 4(3). e4710–e4710. 79 indexed citations

15.

Tothill, Richard W., Adam Kowalczyk, Danny Rischin, et al.. (2005). An Expression-Based Site of Origin Diagnostic Method Designed for Clinical Application to Cancer of Unknown Origin. Cancer Research. 65(10). 4031–4040. 153 indexed citations

16.

Crew, A. Jayne, Julia M.W. Gee, Rina Hui, et al.. (2000). Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation withGRB2 expression. International Journal of Cancer. 88(3). 363–368. 55 indexed citations

17.

Janes, Peter W., et al.. (1997). Structural Determinants of the Interaction between the erbB2 Receptor and the Src Homology 2 Domain of Grb7. Journal of Biological Chemistry. 272(13). 8490–8497. 71 indexed citations

18.

Sutherland, Robert L., Rosemary E. Hall, & Ian W. Taylor. (1983). Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells.. PubMed. 43(9). 3998–4006. 243 indexed citations

19.

Sutherland, Robert L. & V. Craig Jordan. (1981). Non-steroidal antioestrogens : molecular pharmacology and antitumour activity. Andalas University Repository (Andalas University). 42 indexed citations

20.

Gurian, Waldemar, et al.. (1979). ROP volume 41 issue 4 Cover and Front matter. The Review of Politics. 41(4). f1–f4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact